Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It won't be long until the world understands GM-CSF's importance to Covid. We might be frustrated that the stock price didn't immediately rise but it takes time for news to be disseminated. There still isn't one US publication that has covered yesterday's news. But it will come. And then the stock price will melt up.
Any wonder we don't take off like it would seem on good news?
Are the members aware there is a IRS and State of Oregon liens against NP's house for unpaid income taxes.
another $5 million was raised yesterday with that big buy
Is it possible the CYDY Executive Compensation votes were tallied by the Dominion voting machines?
Companies have to apply for the EUA. I have read comments like "the FDA rejected the EUA from CYDY". That is not the case. An 8K will be issued within the allowed window, that CYDY submitted an application for an EUA. This submission would be considered "material news" and CYDY has not revealed that yet!
BBC article about GM-CSF being the key to Covid.
https://www.bbc.com/news/health-56352128
GM-CSF is the cause of Covid death according to today's Imperial College London trial results. This is mammoth for HGEN. Before today, our drug was working on a theory. Today's trial results confirm the theory. A ton of investment money is going to pour into HGEN This article summarizes the trial well:
https://www.dailymail.co.uk/news/article-9346955/Blood-test-spot-Covid-patients-high-risk-dying.html
Today scientists at the Imperial College London are releasing results from a trial the discovered that GM-CSF is the cytokine responsible for Severe Covid and death. HGEN's lenzilumab is a GM-CSF inhibitor.
https://www.dailymail.co.uk/news/article-9346955/Blood-test-spot-Covid-patients-high-risk-dying.html
Exactly! Trials are CYDY's bread and butter- they justify the whole shebang...loans, dilution, salaries, etc.
Without some form of trial hype everything collapses.
If you are right why did the FDA ask for a further trial? If all the data was as negative as you say then FDA is being really irresponsible. Is that what you are implying?
43 patients in LL group
19 patients in Placebo group
You need to establish a common denominator;
43/19 = 2.263 is your multiplier
Now equalize the numerator (on the Placebo side) by multiplying with the above multiplier
7*2.263 = 15.84 ~ 16 is your new mortality number.
LL mortality: 12
Placebo mortality: 16
Difference = 4
Reducing 4 from 16 provides you with just under 25% mortality reduction.
These are four less people who dies in a group of 43 (equivalent)
"All-cause mortality among critically ill patients was 28% (12/43) with leronlimab + SoC
and 37% (7/19) with placebo + SoC
at day 28 (Table4-6).
This
is approximately a 24% relative reduction in mortality."
The numbers are Tiny Tiny -- such that
ONE patient JUST ONE out of 19 makes a difference.
6/19 in the placebo group would have been 31.5%,
Which when you consider 19 patients its simply NOT different from 28 %
If the whole improvement comes down to one patient, it's pretty much impossible to rule out chance.
This is a nothing. An absolute nothing.
Market makers have been trying for price change parity with CYDY for 45 minutes now. Got to within 2 cents (-11 CYDY, vs - .09 for HGEN), and then within one cent (-.16 for CYDY, vs -.15 for HGEN). But no parity yet.
Results are in. 24% reduction in mortality for patients on ventilator compared to placebo. How do you call that a failure?
The stock price drop after the M2M trial took a month to fully happen. The overall drop was from $6.75 on July 21st all the way down to $2.76 on August 18th. Go back and read the posts during that span. The usual suspects were saying the trial results were amazing the entire time the stock was plummeting. After a year of investing your blood, sweat, and tears into this company, it is a bitter pill to swallow accepting that leron is a failure in the Covid arena. But the results are in. It failed.
The good news: CYDY is only down 21 cents.
The bad news: a 21 cent drop is now a 9% drop
The ugly news: it is going to keep bleeding
Philippines is just another carrot that Nader is dangling. The Philippines is poor. Their government isn't going to pay for leron. Few private citizens have enough to pay for leron. With each dose costing over $1,000, the US has always been the only realistic option.
I really don't see it going below $1.50......
You Have to Believe in Leronlimab !
If all of a sudden you don't.....time to find a new pasture.....
If you do........it is really is a NO BRAINER at these Prices...
Is anyone positive about Cytodyn at these prices?
I having trouble deciding if I should load some at this dip.
CYDY still has a much bigger market cap than HGEN. HGEN is a company that has great management. Cameron Durrant has successfully brought a couple dozen drugs to approval. Their mab has always had the support of Big Pharma, the government, and those in the know. Amazing that CYDY could still have a larger market cap. I guess that means that CYDY could keep falling.
It was nice seeing HGEN have a green day when the Nasdaq dropped 2.4%. Lately, HGEN would be red on the days that the Nasdaq was red. Nice to see that trend end.
It prematurely came this morning.
https://wsw.com/webcast/roth35/hgen/1811466
This feels like the M2M trial. What happened with the M2M trial?
Let us say you flipped a coin once a day for 365 days. You might have a good outcome on Mondays. Let us say you had 32 heads and 20 tails on Mondays. You could say that there is statistical significance on the Monday portion of the trial. Obviously, it is only random chance and one day of the week will go to a 32/20 split through sheer luck. That is like this trial. When you slice and dice a study, having 62 patients in one subgroup have a 24% advantage in a category means little to nothing to the FDA. The same as the NEWS2 results in the M2M trial. The FDA knows it could be random. There is a 0% chance of an EUA at this juncture. Maybe the study will be continued with only critical patients. Maybe a study of 1,000 patients. If the results are replicated, then an EUA is possible. A trial needs to meet its primary endpoint for the FDA to believe it is real and not random.
Wait for Monday.
I have heard there is more coming as well.
Let's say you flipped a coin once a day for 365 days. You might have a good outcome on Mondays. Let's say you had 32 heads and 20 tails on Mondays. You could say that there is statistical significance on the Monday portion of the trial. Obviously, it is only random chance and one day of the week is going to a 32/20 split through sheer luck. That is like this trial. When you slice and dice a study, having 62 patients in one subgroup have a 24% advantage in a category means little to nothing to the FDA. The same as the NEWS2 results in the M2M trial. The FDA knows it could be random. There is a 0% chance of an EUA at this juncture. Maybe the study will be continued with only critical patients. Maybe a study of 1,000 patients. If the results are replicated, then an EUA is possible. A trial needs to meet its primary endpoint for the FDA to believe it is real and not random.
CYDY dropped to $1.63 on November 10th due to positive vaccine news. This is far worse. I wonder if the stock price could go sub-$1.00 on Monday?
I wonder if the South Korean stock activity today was due to something real. If trial results are good, it makes sense that Humanigen would be in contact with their production partners to make sure they are ready to produce product. They certainly are going to want up-to-date information if they are preparing their presentation with the FDA for an EUA. There are a lot of different ways in which insider information can be leaked.
We had an almost normal gap in our spread for quite awhile.
Cramer mentions Humanigen at the 15:00 point in the video.
coincidentally things are being made to look very hopeless before anyone even has a chance to see the data.
Does anyone else get the feel there is an orchestrated sense of doom and hopelessness being painted lately?
So the government makes a clerical error and it costs our market cap $100 million? Nice. At least the stock price should rebound since the fall was based on a false premise.
I keep coming back to the overall success that the Mayo Clinic has had treating Covid. 1% of those treated for Covid at Mayo passed away. The national average is 3%. That is circumstantially perfect for lenz having a great trial. And Mayo's ICU mortality rate is 11.9% which is incredibly low and could only have been achieved if lenz is super effective.
https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-model-of-care-and-research-leads-to-favorable-outcomes-for-patients-with-covid-19/
Included in the research during the study period were 7,891 patients who tested positive for COVID-19 and were treated at Mayo Clinic. Of those patients, 897 required hospitalization ? 354 in an ICU. An intensive, multilayered approach was used to manage patient care, leveraging clinical trials and available therapies, and using remote monitoring tools for patients before or after hospital care.
Just over 77.5% of hospitalized patients received at least one COVID-19 therapy, such as an antiviral drug, systemic steroid, immunomodulatory monoclonal antibody or convalescent plasma. Nearly one-quarter of hospitalized patients received two therapies, most commonly a combination of steroids and antiviral medications.
The research, published in Mayo Clinic Proceedings, finds that mortality rates were lower than the national and international averages, and lower than what has been reported in other major studies and expanded-access programs. An overall mortality rate of 1.1% was reported for patients treated at Mayo, with inpatient mortality of 7.1% and ICU mortality of 11.9%.
Covid stocks always rebound.
Patience is the hardest thing to master. People always looking for a fast lane ride.
We close green $25 plus!! Thoughts?
just looking for a COVID pump play